New drug for eczema tested in healthy volunteers
NCT ID NCT06214481
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study tested a single dose of rocatinlimab in 20 healthy Chinese adults to see how the drug moves through the body and if it is safe. The drug is being developed for atopic dermatitis (eczema). No treatment was given—only observation of drug levels and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Huashan Hospital Affiliated to Fudan University?
Shanghai, 200040, China
Conditions
Explore the condition pages connected to this study.